Published in Circulation on June 23, 2003
Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ (2011) 3.74
Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress (2009) 1.61
Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest (2008) 1.57
How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology (2008) 1.56
Acute fluoxetine treatment induces slow rolling of leukocytes on endothelium in mice. PLoS One (2014) 1.44
Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med (2008) 1.42
General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart (2005) 1.41
Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur Heart J (2010) 1.24
Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. Front Psychol (2012) 1.20
Depression and cardiovascular comorbidity. Dialogues Clin Neurosci (2007) 1.04
Cell-based screening identifies paroxetine as an inhibitor of diabetic endothelial dysfunction. Diabetes (2012) 0.92
Variation in ITGB3 has sex-specific associations with plasma lipoprotein(a) and whole blood serotonin levels in a population-based sample. Hum Genet (2005) 0.89
Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI). Eur J Clin Pharmacol (2007) 0.89
Antidepressants, antiplatelets and bleeding: one more thing to worry about? CMAJ (2011) 0.86
The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression. Br J Clin Pharmacol (2011) 0.86
Clinical depression, antidepressant use and risk of future cardiovascular disease. Eur J Epidemiol (2013) 0.85
Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression. Psychopharmacology (Berl) (2011) 0.84
Possible Role of Platelet GluR1 Receptors in Comorbid Depression and Cardiovascular Disease. Cardiovasc Psychiatry Neurol (2009) 0.82
Selective serotonin reuptake inhibitor use is associated with right ventricular structure and function: the MESA-right ventricle study. PLoS One (2012) 0.82
Treatment of anxiety and depressive disorders in patients with cardiovascular disease. BMJ (2004) 0.81
Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies. Br J Clin Pharmacol (2014) 0.80
Use of selective serotonin reuptake inhibitors and outcomes in pulmonary arterial hypertension. Chest (2013) 0.79
A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders. Mol Autism (2013) 0.78
Emotional predictors and behavioral triggers of acute coronary syndrome. Cleve Clin J Med (2008) 0.78
Selective serotonin reuptake inhibitors and myocardial infarction. Circulation (2004) 0.77
Use of antidepressants and the risk of myocardial infarction in middle-aged and older adults: a matched case-control study. Eur J Clin Pharmacol (2015) 0.77
Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD). Trials (2009) 0.77
Platelets and cardiac arrhythmia. Front Physiol (2010) 0.76
Risk of Stroke Among Older Medicare Antidepressant Users With Traumatic Brain Injury. J Head Trauma Rehabil (2016) 0.75
Teaching an old drug new tricks: can paroxetine ease the burden of cardiovascular disease in diabetes? Diabetes (2013) 0.75
Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality. Cardiol Res Pract (2009) 0.75
Depression in vascular pathologies: the neurologist's point of view. Vasc Health Risk Manag (2011) 0.75
Impact of antidepressants use on risk of myocardial infarction: A systematic review and meta-analysis. Indian J Pharmacol (2015) 0.75
Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies. Eur J Clin Pharmacol (2017) 0.75
Role of computerized physician order entry systems in facilitating medication errors. JAMA (2005) 26.32
The continuing unethical conduct of underpowered clinical trials. JAMA (2002) 10.34
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis (2005) 5.25
The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology (2002) 4.98
Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med (2007) 4.56
Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med (2007) 4.26
Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation (2010) 3.78
Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol (2005) 3.11
Meta-analysis of the effect of an essential oil-containing mouthrinse on gingivitis and plaque. J Am Dent Assoc (2015) 3.07
The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol (2005) 3.06
Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage (2003) 3.05
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood (2010) 2.93
Clinical risk factors for primary graft failure following lung transplantation. Chest (2003) 2.92
Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int (2010) 2.59
The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med (2005) 2.57
Hemodynamics and survival of patients with portopulmonary hypertension. Liver Transpl (2005) 2.53
Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team. Clin Trials (2009) 2.49
Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Arch Intern Med (2004) 2.49
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ (2002) 2.46
Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol (2011) 2.36
Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction. Ann Intern Med (2005) 2.34
Randomized trial of 5 dollars versus 10 dollars monetary incentives, envelope size, and candy to increase physician response rates to mailed questionnaires. Med Care (2002) 2.30
A test of financial incentives to improve warfarin adherence. BMC Health Serv Res (2008) 2.23
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc (2002) 2.20
Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression. J Clin Epidemiol (2007) 2.19
Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. J Am Coll Cardiol (2011) 2.09
Use of ClinicalTrials.gov to estimate condition-specific nocebo effects and other factors affecting outcomes of analgesic trials. J Pain (2013) 2.06
Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation (2009) 2.06
Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch Intern Med (2003) 2.02
Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. J Clin Epidemiol (2004) 2.02
Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction. Circ Heart Fail (2011) 2.01
A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev (2006) 1.93
Impact of primary graft failure on outcomes following lung transplantation. Chest (2005) 1.92
Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest (2003) 1.90
Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency. Am Heart J (2003) 1.89
Medication adherence: a call for action. Am Heart J (2011) 1.85
Construct validity of the definition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant (2010) 1.85
Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics (2011) 1.84
Evaluating the impact of database heterogeneity on observational study results. Am J Epidemiol (2013) 1.83
Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf (2010) 1.78
Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion (2002) 1.77
The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin. J Am Coll Cardiol (2004) 1.76
Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst (2005) 1.75
Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol (2005) 1.74
The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysis. J Am Coll Cardiol (2006) 1.72
Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial. Trials (2010) 1.72
Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure. J Card Fail (2011) 1.70
An international survey indicated that unpublished systematic reviews exist. J Clin Epidemiol (2009) 1.70
Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol (2013) 1.64
Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia. Pharmacoepidemiol Drug Saf (2011) 1.63
Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. Cancer Epidemiol Biomarkers Prev (2007) 1.62
Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer (2002) 1.62
Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial. Stroke (2002) 1.62
Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: a prospective randomized study. Heart Rhythm (2007) 1.59
Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004. JAMA (2008) 1.57
Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure. Circulation (2009) 1.55
Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab (2004) 1.55
Factors affecting decisions to seek treatment for sick children in Kerala, India. Soc Sci Med (2003) 1.54
The accuracy of venous leg ulcer prognostic models in a wound care system. Wound Repair Regen (2004) 1.48
Genetic warfarin dosing: tables versus algorithms. J Am Coll Cardiol (2011) 1.43
Methylphenidate and risk of serious cardiovascular events in adults. Am J Psychiatry (2012) 1.42
Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. Diabetes Care (2002) 1.42
Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure. J Card Fail (2013) 1.41
Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. J Natl Cancer Inst (2006) 1.39
Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction. Am J Cardiol (2004) 1.38
Is improved survival a class effect of angiotensin-converting enzyme inhibitors? Ann Intern Med (2004) 1.35
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. Thromb Haemost (2011) 1.35
Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study. J Gen Intern Med (2007) 1.35
Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure. Am J Cardiol (2010) 1.34
Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity. Pharmacogenomics (2007) 1.34
Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Arch Intern Med (2004) 1.32
Searching one or two databases was insufficient for meta-analysis of observational studies. J Clin Epidemiol (2005) 1.29
Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53. Chem Res Toxicol (2002) 1.28
Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Am J Epidemiol (2006) 1.27
Medication safety in older adults: home-based practice patterns. J Am Geriatr Soc (2005) 1.24
Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes. Eur J Heart Fail (2011) 1.22
Diabetic neuropathic foot ulcers: predicting which ones will not heal. Am J Med (2003) 1.21
Hormone replacement therapy regimens and breast cancer risk(1). Obstet Gynecol (2002) 1.20
Risk factors for pressure ulcers among elderly hip fracture patients. Wound Repair Regen (2003) 1.19
Prospective alpha allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) trial. Clin Trials (2010) 1.18
Effectiveness of a two-part educational intervention to improve hypertension control: a cluster-randomized trial. Pharmacotherapy (2006) 1.17
Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr (2008) 1.17
Risk factors for nonadherence to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf (2008) 1.15
Ethnic differences in warfarin maintenance dose requirement and its relationship with genetics. Pharmacogenomics (2008) 1.14
Cisapride and ventricular arrhythmia. Br J Clin Pharmacol (2008) 1.13
Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass. Anesth Analg (2002) 1.12
Epidemiologic features of the presentation of critical congenital heart disease: implications for screening. Pediatrics (2008) 1.09
Diabetic neuropathic foot ulcers and amputation. Wound Repair Regen (2005) 1.09
Diagnostic codes for sudden cardiac death and ventricular arrhythmia functioned poorly to identify outpatient events in EPIC's General Practice Research Database. Pharmacoepidemiol Drug Saf (2008) 1.09
Association between pulmonary fibrosis and coronary artery disease. Arch Intern Med (2004) 1.08
Systematic review of the effect of daily alcohol intake on blood pressure. Am J Hypertens (2005) 1.08
Limitations of current risk-adjustment models in the era of coronary stenting. Am Heart J (2003) 1.07
Meta-analytic methods for pooling rates when follow-up duration varies: a case study. BMC Med Res Methodol (2004) 1.06
Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials. Eur J Heart Fail (2011) 1.06